Choose between Carraro India with its strong growth or Senores Pharma with high market demand. Decide your bet by!

Unlisted shares of Senores Pharmaceuticals Ltd are currently trading at Rs 611 in the grey market, reflecting a premium of Rs ...

Senores Pharmaceuticals IPO receives strong response on Day 1, with retail investors leading the way, closing on4.

Senores Pharmaceuticals' IPO received 13.88 times subscription on Day 2, with strong demand from retail and institutional ...

The Senores Pharmaceuticals’ public issue will close for public bidding on Tuesday, December 24. The IPO has received 1.78x ...

The grey market premium of Senores Pharmaceuticals was Rs 220 as of 4:28 p.m. on Monday, according to Chittorgarh's unit ...

Senores Pharmaceuticals' initial public offering garnered 13.88 times subscription on Monday, the day two of bidding.

Senores Pharmaceutical IPO opened for subscription on 20th December 2024, and will remain open for subscription till December ...

Senores Pharmaceuticals' IPO witnessed an impressive 13.88 times subscription, amassing bids for 11.8 crore shares compared ...

Ahead of the IPO, Senores Pharmaceuticals on Thursday, 19 December 2024, raised Rs 260.62 crore from anchor investors. The board allotted 66.65 lakh shares at Rs 391 each to 20 anchor investors.

Senores Pharmaceuticals IPO comprises a fresh issue of shares worth Rs 500 crore and an offer-for-sale (OFS) of up to ...

Amid the ongoing flurry of IPOs, three issues- Ventive Hospitality, Senores Pharmaceuticals and Carraro India- which opened ...